Mackenzie Tatananni

Columnista

8 piezas en los últimos 90 días · Economía y finanzas

Escribe en:Barrons (8)

Columnas y opinión

“What GSK Needs to Do After Weak Vaccine Sales Spoil an Earnings Beat”

Barrons · Hace 8 h

“Biogen Crushes Earnings Estimates. As Old Blockbusters Fade, New Bets Pick Up the Slack.”

Barrons · Hace 12 h

2 Reasons Why GE HealthCare Stock Is Climbing After Earnings

Barrons · Hace 10 h

Moderna Has Its Doubters. CEO Bancel Plans to Answer With a Cancer Shot.

Barrons · Hace 1 d

Moderna CEO Says Its Cancer Vaccine Isn’t a Disappointment, It’s a Blockbuster

Barrons · Hace 2 d

Applied Digital’s Co-Founders Load Up on Shares as the Stock Hit a One-Year Low

Barrons · Hace 5 d

Bitcoin Crosses $86,000 on Fed Pause Hopes. Strategy Leads Crypto Stocks Higher.

Barrons · 2 oct

Moderna Stock Jumps. Its mRNA Cancer Vaccine Is Getting Ready for Its Next Big Test.

Barrons · 21 sep